Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biology of cachexia

M J Tisdale

    Journal of the National Cancer Institute
    |December 10, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Cancer cachexia, a wasting syndrome, involves muscle and fat loss, impacting survival. Eicosapentaenoic acid shows promise in stabilizing wasting and energy expenditure in pancreatic cancer patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCg) Attenuates Skeletal Muscle Atrophy in a Rat Model of Sarcopenia.

    The Journal of frailty & aging·2016
    Same author

    Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.

    British journal of cancer·2014
    Same author

    Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle.

    Cellular signalling·2012
    Same author

    Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).

    British journal of cancer·2011
    Same author

    Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat.

    International journal of obesity (2005)·2010
    Same author

    Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse.

    International journal of obesity (2005)·2010

    Area of Science:

    • Oncology
    • Metabolism
    • Biochemistry

    Background:

    • Cancer cachexia affects approximately 50% of cancer patients, characterized by adipose tissue and skeletal muscle mass loss.
    • This wasting syndrome is associated with decreased survival time and impaired respiratory muscle function, not fully explained by anorexia or nutritional supplementation.
    • Elevated resting energy expenditure, increased Cori cycle activity, and altered metabolic cycling are observed in cachexia, suggesting complex underlying mechanisms.

    Purpose of the Study:

    • To explore the complex mechanisms of wasting in cancer cachexia.
    • To investigate the role of cytokines and other catabolic factors in cancer cachexia.
    • To evaluate the potential of eicosapentaenoic acid in managing cancer cachexia.

    Main Methods:

    Related Experiment Videos

  • Review of clinical and laboratory studies on cancer cachexia mechanisms.
  • Analysis of cytokine involvement and other proposed mediators.
  • Examination of xenograft models and catabolic factor actions.

    • Main Results:

    • Cytokines alone do not fully explain the wasting process in cancer cachexia.
    • Cachexia can occur in models without cytokine involvement, indicating other catabolic factors.
    • Eicosapentaenoic acid demonstrated an ability to attenuate catabolic factors and stabilize wasting and energy expenditure in pancreatic cancer patients.

    Conclusions:

    • Cancer cachexia is a multifactorial syndrome involving more than just cytokines.
    • Catabolic factors directly impacting tissues play a significant role in cancer cachexia development.
    • Eicosapentaenoic acid represents a potential therapeutic strategy for managing cancer cachexia.